Search for: "Generic Pharmaceutical Association" Results 81 - 100 of 3,014
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Mar 2013, 1:56 am by Ben Vernia
On March 5, the Department of Justice announced that generic drug maker Par Pharmaceuticals, Inc., entered a guilty plea and agreed to pay a combined $45 million to settle criminal and civil charges that it promoted Megace ES off-label. [read post]
15 Oct 2014, 11:52 am
"Supreme Court weighs generic drug dispute": Sam Hananel of The Associated Press has this report. [read post]
18 Jun 2019, 8:59 pm by Leader
According to the Association for Accessible Medicines (AAM), a trade group that represents generic drug manufacturers, said it “believes in compliance with all competition and antitrust laws. [read post]
12 Sep 2008, 1:40 am
Medicis Pharmaceutical (07-1524), Prasco tried to get a declaratory judgment that one of its products did not infringe various patents owned by Medicis Pharmaceutical Corp. and Imaginative Research Associates. [read post]
17 Sep 2007, 4:33 pm
[JURIST] New York Attorney General Andrew Cuomo and New York City Mayor Michael Bloomberg [official websites] Monday filed a joint lawsuit [press release] against pharmaceutical giant Merck [corporate website], alleging that the company misrepresented known dangers associated with arthritis drug Vioxx [Merck materials; JURIST news archive], causing millions of taxpayer dollars to be wasted. [read post]
3 Oct 2013, 9:49 pm by Patent Docs
By Donald Zuhn -- Yesterday, we noted that the Generic Pharmaceutical Association (GPhA) recently expressed its opposition to a California bill (SB-598) that would authorize a pharmacist to select a biosimilar when filling a prescription order for a prescribed biological product, provided that the prescriber did not personally indicate "Do not substitute" (see "GPhA Opposes California Biosimilar Bill; Points to Report on Savings from Biosimilars"). [read post]
4 Feb 2014, 8:00 am by Pete Strom
Louisiana Court Overturns $258 Million Penalty Against J&J for Risperdal Marketing On Tuesday, January 28th, pharmaceutical giant Johnson & Johnson won an appeal in Louisiana Supreme Court to overturn a $258 million penalty for marketing practices associated with its antipsychotic drug, Risperdal. [read post]
19 Nov 2021, 6:19 am by Robert Kraft
Texas Attorney General announced a $290 million settlement agreement Tuesday with pharmaceutical giant Johnson & Johnson over what the state claims were deceptive marketing tactics that contributed to the ongoing opioid crisis. [read post]
8 Mar 2011, 3:11 pm by JA Hodnicki
(North Wales, PA) Jonathan Wasserman Vice President & Associate General Bristol-Myers Squibb... [read post]
17 Sep 2023, 9:06 pm by Patent Docs
This year's co-chairs are Laura DeMoor, IP Associate General Counsel, Baxter Healthcare Corp.; Andrea D. [read post]
9 Apr 2010, 9:55 pm by Patent Docs
The IPO webinar will provide an overview of the healthcare reform measure that creates a regulatory pathway for generic versions of large-molecule biotech drugs, which bears some resemblance to the longstanding Hatch-Waxman regime that sets out how generic drug companies can challenge patents held by pharmaceutical companies on small-molecule medicines. [read post]
15 May 2023, 1:00 pm by Steve Brachmann
The Supreme Court also denied Teva Pharmaceuticals’ petition to review its appeal of the Federal Circuit’s “skinny label” induced infringement ruling over its generic version of carvedilol. [read post]
15 May 2023, 1:00 pm by Steve Brachmann
The Supreme Court also denied Teva Pharmaceuticals’ petition to review its appeal of the Federal Circuit’s “skinny label” induced infringement ruling over its generic version of carvedilol. [read post]
The world’s largest manufacturer of generic pharmaceuticals, Israeli-based Teva Pharmaceutical Industries Ltd. [read post]
28 Sep 2012, 11:15 am by Todd M. Nosher
., payments made by branded pharmaceutical patent holders to generic challengers to postpone market entry of proposed generic products). [read post]
1 May 2009, 4:03 am
The issue of allowing manufacture for export for pharmaceuticals during an extended patent term has moved on a bit since my recent blog post and the podcast interview we did. [read post]
23 Dec 2014, 12:26 pm
Amneal is a pharmaceutical company that develops, manufactures, markets and distributes generic pharmaceutical products for sale in the United States. [read post]
12 Jan 2013, 11:29 am by admin
While the Canadian Competition Act does contain exceptions for certain types of collective bargaining activities, these are limited to certain union and employer association activities (i.e., apply to unions and employer associations not trade or professional associations generally). [read post]
16 Aug 2012, 10:01 am by James McArdle
Jovana Grbic explores a recent case on generic lidocaine patches ACTION:  Infringement of U.S. [read post]